Skip to main content
Top
Published in: Acta Neurologica Belgica 1/2021

01-02-2021 | Dementia | Original article

Dementia with Lewy bodies in first-generation immigrants in a European memory clinic

Authors: Kurt Segers, Florence Benoit, Jean-Marie Meyts, Gérald Glibert, Sophie Levy, Murielle Surquin

Published in: Acta Neurologica Belgica | Issue 1/2021

Login to get access

Abstract

We wanted to explore possible differences in disease presentation, frequency, and age of onset of dementia with Lewy bodies (DLB) between first-generation immigrants (FGI) and patients born in Belgium (PBIB). We conducted a retrospective study on all patients of our Memory Clinic between June 1, 2010 and January 31, 2020. A synucleinopathy was diagnosed in 150 of 2702 patients (5.5%): 91 received a diagnosis of DLB (3.4%). FGI were two times more likely to receive a diagnosis of DLB, due to a higher prevalence in North-Africans and Latin-Americans. Visual hallucinations were less frequent in North-Africans than in other immigrants. FGI were younger than PBIB and reported more often parasomnia. Our data suggest a higher risk for DLB in certain immigrant groups. Especially for North-African patients, a genetic factor can be suspected, namely mutations in Leucine-rich repeat kinase 2 (LRRK2). Memory clinics with a high rate of FGI may provide interesting data and insights into the prevalence of DLB, genetic and environmental differences.
Literature
1.
go back to reference Jellinger KA, Korczyn AD (2018) Are dementia with Lewy bodies and Parkinson's disease dementia the same disease? BMC Med 16:34CrossRef Jellinger KA, Korczyn AD (2018) Are dementia with Lewy bodies and Parkinson's disease dementia the same disease? BMC Med 16:34CrossRef
2.
go back to reference Galvin JE, Balasubramaniam M. (2013) Lewy body dementia: the under-recognized but common FOE. In: Cerebrum: the Dana forum on brain science, p 13 Galvin JE, Balasubramaniam M. (2013) Lewy body dementia: the under-recognized but common FOE. In: Cerebrum: the Dana forum on brain science, p 13
3.
go back to reference Segers K, Benoit F, Colson C, Kovac V, Nury D, Vanderaspoilden V (2013) Pioneers in migration, pioneering in dementia: first generation immigrants in a cosmopolitan memory clinic. Acta Neurol Belg 113:435–440CrossRef Segers K, Benoit F, Colson C, Kovac V, Nury D, Vanderaspoilden V (2013) Pioneers in migration, pioneering in dementia: first generation immigrants in a cosmopolitan memory clinic. Acta Neurol Belg 113:435–440CrossRef
4.
go back to reference McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG et al (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 89:88–100CrossRef McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG et al (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 89:88–100CrossRef
5.
go back to reference Yamada M, Komatsu J, Nakamura K, Sakai K, Samuraki-Yokohama M, Nakajima K, Yoshita M (2020) Diagnostic criteria for dementia with Lewy bodies: updates and future directions. J Mov Disord 13:1–10CrossRef Yamada M, Komatsu J, Nakamura K, Sakai K, Samuraki-Yokohama M, Nakajima K, Yoshita M (2020) Diagnostic criteria for dementia with Lewy bodies: updates and future directions. J Mov Disord 13:1–10CrossRef
6.
go back to reference Dubois B, Feldmann HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G et al (2007) Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6:734–746CrossRef Dubois B, Feldmann HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G et al (2007) Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6:734–746CrossRef
7.
go back to reference Custodio N, Wheelock A, Thumala D, Slachevsky A (2017) Dementia in Latin America: epidemiological evidence and implications for public policy. Front Aging Neurosci 13:221CrossRef Custodio N, Wheelock A, Thumala D, Slachevsky A (2017) Dementia in Latin America: epidemiological evidence and implications for public policy. Front Aging Neurosci 13:221CrossRef
8.
go back to reference Benamer HT, de Silva R, Siddiqui KA, Grosset DG (2008) Parkinson's disease in Arabs: a systematic review. Mov Disord 23:1205–1210CrossRef Benamer HT, de Silva R, Siddiqui KA, Grosset DG (2008) Parkinson's disease in Arabs: a systematic review. Mov Disord 23:1205–1210CrossRef
9.
go back to reference Ben-Joseph A, Marshal CR, Lees AJ, Noyce AJ (2020) Ethnic variation in the manifestation of Parkinson’s disease: a narrative review. J Park Dis 10:31–45 Ben-Joseph A, Marshal CR, Lees AJ, Noyce AJ (2020) Ethnic variation in the manifestation of Parkinson’s disease: a narrative review. J Park Dis 10:31–45
10.
go back to reference Suemoto CK, Ferretti-Rebustini RE, Rodriguez RD, Leite RE, Soterio L, Brucki SM, Spera RR, Cippiciani TM, Farfel JM, Filho AC et al (2017) Neuropathological diagnoses and clinical correlates in older adults in Brazil. PLoS Med 14:e1002267CrossRef Suemoto CK, Ferretti-Rebustini RE, Rodriguez RD, Leite RE, Soterio L, Brucki SM, Spera RR, Cippiciani TM, Farfel JM, Filho AC et al (2017) Neuropathological diagnoses and clinical correlates in older adults in Brazil. PLoS Med 14:e1002267CrossRef
11.
go back to reference Ogunniyi A, Daif AK, Al-Rajeh S, AbdulJabbar M, Al-Tahan AR, Al-Bunyan M, Shamina AR (1998) Dementia in Saudi Arabia: experience from a university hospital. Acta Neurol Scand 98:116–120CrossRef Ogunniyi A, Daif AK, Al-Rajeh S, AbdulJabbar M, Al-Tahan AR, Al-Bunyan M, Shamina AR (1998) Dementia in Saudi Arabia: experience from a university hospital. Acta Neurol Scand 98:116–120CrossRef
12.
go back to reference Benamer HT, de Silva R (2010) LRRK2 G2019S in the North African population: a review. Eur Neurol 63:321–325CrossRef Benamer HT, de Silva R (2010) LRRK2 G2019S in the North African population: a review. Eur Neurol 63:321–325CrossRef
13.
go back to reference Zhu X, Babar A, Siedlak SL, Yang Q, Ito G, Iwatsubo T, Smith MA, Perry G, Chen SG (2006) LRRK2 in Parkinson's disease and dementia with Lewy bodies. Mol Neurodegener 1:17CrossRef Zhu X, Babar A, Siedlak SL, Yang Q, Ito G, Iwatsubo T, Smith MA, Perry G, Chen SG (2006) LRRK2 in Parkinson's disease and dementia with Lewy bodies. Mol Neurodegener 1:17CrossRef
14.
go back to reference Ben Romdhan S, Farhat N, Nasri A, Lesage S, Hdiji O, Ben Djebara M, Landoulsi Z, Stevanin G, Brice A, Damak M et al (2018) LRRK2 G2019S Parkinson's disease with more benign phenotype than idiopathic. Acta Neurol Scand 138:425–431CrossRef Ben Romdhan S, Farhat N, Nasri A, Lesage S, Hdiji O, Ben Djebara M, Landoulsi Z, Stevanin G, Brice A, Damak M et al (2018) LRRK2 G2019S Parkinson's disease with more benign phenotype than idiopathic. Acta Neurol Scand 138:425–431CrossRef
15.
16.
go back to reference Ardila A, Bertolucci PH, Braga LW (2010) Illiteracy: the neuropsychology of cognition without reading. Arch Clin Neuropsy 25:689–712CrossRef Ardila A, Bertolucci PH, Braga LW (2010) Illiteracy: the neuropsychology of cognition without reading. Arch Clin Neuropsy 25:689–712CrossRef
17.
go back to reference Pont-Sunyer C, Iranzo A, Gaig C, Fernández-Arcos A, Vilas D, Valldeoriola F, Compta Y, Fernández-Santiago R, Fernández M, Bayés A et al (2015) Sleep disorders in Parkinsonian and nonparkinsonian LRRK2 mutation carriers. PLoS ONE 15:10 Pont-Sunyer C, Iranzo A, Gaig C, Fernández-Arcos A, Vilas D, Valldeoriola F, Compta Y, Fernández-Santiago R, Fernández M, Bayés A et al (2015) Sleep disorders in Parkinsonian and nonparkinsonian LRRK2 mutation carriers. PLoS ONE 15:10
18.
go back to reference Saunders-Pullman R, Alcalay RN, Mirelman A, Wang C, San Luciano M, Ortega RA, Glickman A, Raymond D, Mejia-Santana H, Doan N et al (2015) REM sleep behavior disorder, as assessed by questionnaire, in G2019S LRRK2 mutation PD and carriers. Mov Disord 30:1834–1839CrossRef Saunders-Pullman R, Alcalay RN, Mirelman A, Wang C, San Luciano M, Ortega RA, Glickman A, Raymond D, Mejia-Santana H, Doan N et al (2015) REM sleep behavior disorder, as assessed by questionnaire, in G2019S LRRK2 mutation PD and carriers. Mov Disord 30:1834–1839CrossRef
19.
go back to reference Boot BP, Orr CF, Ahlskog JE, Ferman TJ, Roberts R, Pankratz VS, Dickson DW, Parisi J, Aakre JA, Geda YE et al (2013) Risk factors for dementia with Lewy bodies: a case-control study. Neurology 81:833–840CrossRef Boot BP, Orr CF, Ahlskog JE, Ferman TJ, Roberts R, Pankratz VS, Dickson DW, Parisi J, Aakre JA, Geda YE et al (2013) Risk factors for dementia with Lewy bodies: a case-control study. Neurology 81:833–840CrossRef
20.
go back to reference NCD Risk Factor Collaboration (NCD-RisC) (2016) Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet 387:1513–1530CrossRef NCD Risk Factor Collaboration (NCD-RisC) (2016) Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet 387:1513–1530CrossRef
21.
go back to reference Frigerio R, Fujishiro H, Maraganore DM, Klos KJ, DelleDonne A, Heckman MG, Crook JE, Josephs KA, Parisi JE, Boeve BF, Dickson DW, Ahlskog JE et al (2009) Comparison of risk factor profiles in incidental Lewy body disease and Parkinson disease. Arch Neurol 66:1114–1119CrossRef Frigerio R, Fujishiro H, Maraganore DM, Klos KJ, DelleDonne A, Heckman MG, Crook JE, Josephs KA, Parisi JE, Boeve BF, Dickson DW, Ahlskog JE et al (2009) Comparison of risk factor profiles in incidental Lewy body disease and Parkinson disease. Arch Neurol 66:1114–1119CrossRef
22.
go back to reference Boulos C, Yaghi N, El Hayeck R (2019) Nutritional risk factors, microbiota and Parkinson’s disease: what is the current evidence? Nutrients 11:1896CrossRef Boulos C, Yaghi N, El Hayeck R (2019) Nutritional risk factors, microbiota and Parkinson’s disease: what is the current evidence? Nutrients 11:1896CrossRef
23.
go back to reference Yan R, Zhang J, Park HJ, Park ES, Oh S, Zheng H, Junn E, Voronkov M, Stock JB, Mouradian MM (2018) Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson’s disease and DLB. PNAS USA 115:E12053–E12062CrossRef Yan R, Zhang J, Park HJ, Park ES, Oh S, Zheng H, Junn E, Voronkov M, Stock JB, Mouradian MM (2018) Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson’s disease and DLB. PNAS USA 115:E12053–E12062CrossRef
24.
go back to reference Mukadam N, Cooper C, Basi B, Livingston G (2011) Why do ethnic elders present later to UK dementia services? A qualitative study”. Int Psychogeriatr 23:1070–1077CrossRef Mukadam N, Cooper C, Basi B, Livingston G (2011) Why do ethnic elders present later to UK dementia services? A qualitative study”. Int Psychogeriatr 23:1070–1077CrossRef
Metadata
Title
Dementia with Lewy bodies in first-generation immigrants in a European memory clinic
Authors
Kurt Segers
Florence Benoit
Jean-Marie Meyts
Gérald Glibert
Sophie Levy
Murielle Surquin
Publication date
01-02-2021
Publisher
Springer International Publishing
Published in
Acta Neurologica Belgica / Issue 1/2021
Print ISSN: 0300-9009
Electronic ISSN: 2240-2993
DOI
https://doi.org/10.1007/s13760-020-01492-2

Other articles of this Issue 1/2021

Acta Neurologica Belgica 1/2021 Go to the issue